Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

194 viremia * virus

12th World AIDS Conference

Keyword

Abstract --

dicaid managed care in Virginia (Va)/Planning for statewide HIV/
V infection/Aerococcus viridans as a causative agent of pleural e
e of HIV-1 on infectious virion assembly/The impact of interaction
formation of O-shaped particles associate with p17/Immun
nvelope gp120 from the /Saliva neutralizes HIV-1 infection b
itopes shared by HIV-1 virions of different genetic subtypes (clade
iral debris rather than /The antibody response in HIV-1 in
on progressors, and its viro-immunological correlates/Prevalen

d subjects/ACTG 364: Virologic
r mesylate (Viracept~)/
tonavir plus stavudine/
mission study (WITS)/
eated with ZDV + ddC/
viral therapy (HAART)/
ed injection drug users/
resistance to efavirenz/
ts associated with poor virologic
nologic, phenotypic and
trial/Immunologic and
vir and inmunologic and
are less likely to have a
ecessary for long-term
redictors of duration of
nical, immunologic, and
ogic improvement after
dence and predictors of
AART)/Risk factors for
al load as a predictor of
tment program/Lesser
epant immunologic and
ents. Immunologic and
idovudine diminish the
se are associated with
ent of immunologic and
ion of the magnitude of
nd their correlation with
te practice/Clinical and
pathy/Immunologic and
wasting independent of
ospective study using 3
s in an HIV clinic cohort/ Virologic
with protease inhibitor/
-experienced patients/
standard triple therapy/
ble NRTI combinations/
RT is not hard enough -
n HIV-infected patients/
ors with high virus load/
ing to initial CD4 count/
ost-specific factors and virologicc

r efficacy of nelfinavir (NFV) and/o
response-plasma drug concentr
long-term results of a double pro,immunologic and clinical indicat
efficacy of 3TC + d4T vs. 3TC +
findings in patients with paradoxi
response to antiretroviral therap
resistance to efavirenz/
outcomes/Detection of HIV RNA
analyses/Immune activation in
markers as indicators of clinical o
parameters in HIV-patients/Corr
response in a meta-analysis of t
response/How low is low enoug
suppression in a meta-analysis o
markers/Symptomatic HIV-1 ser
relapse in patients receiving high
failure of antiretroviral triple drug
failure in a cohort of HIV patients
response to triple therapy/Are th
response to antiretroviral therap

42414
32263
379*/11131
11138
21143
11178
331*/31104
60250
125*/12203
12304
12313
13368
22376
32286
499*/32407
41213
12128
12147
12234
12286
12361
12364
12365
21116
22342
22349
22351
22359
23398

responses in HIV-infected patien 342*/32259

response/Application of a genot
response to stavudine plus didan
outcomes in CCTG 570: A clinica
parameters/Durability of undete
suppression in patients on aggre
and immunologic parameters/In
outcomes after HAART in private
findings in HIV-related cardiomy
response to HAART - A case stu
assays/Early diagnosis of HIV-1
al response to protease inhibitor
follow-up of HIV infected patie
and immunological effectivene
efficacy and drug levels of nelfi
response in patients switching
failure after 12 months of treat
failure and adherence to antire
and immunological characteriz
response to protease inhibitoral failure/Viral dynamics in HIV in

onths of follow-up/HIV markers in a cohort of LTNPs:
El)/lmmunological and effects of combination antiretro
ons of absence of initial response/Protease inhibitors c
y of immunological and parameters in CCR-5 homozy
ver histopathology and findings in patients with concur
ase gene mutations on response to nelfinavir/Impact
are highly predictive of treatment failure in patients usi
ia/Immunological and analysis of a triple combination
DS-NHL pts)/Effect on and immunological parameter
Predictors of long-term and immunological response t
ating ethnography and virology in the study of viral transmission i
Sensivity evaluation of Vironostika Uni-Form II plus O with sampl
de UC-781 is a potential virucidal drug/The thiocarboxanilide UCo anti-HIV-1 and HIV-2 properties of the F-5~ gel, a pote
s (FIV): Evaluation of its virulence /A thermoresistant strain of felin
ment of introduction of virulent HIV-1 strains into current AIDS ris
/Identification of a new virus-associated epitope inducing antibo
ypes (clades) by a new virus-binding assay/Mapping conserved
enic immunodeficiency virus-host systems/Lessons learned from
man immunodeficiency virus-related non-Hodgkin's lymphoma (H
HIV replication requires virus-specific helper and CTL function an
natally infected infants/ Virus detection, virus load, and disease pr
nterferes with wild-type virus infectivity/Mutations in the leucine zi
dney blood bank cohort evolution and quantitation of virus att
man immunodeficiency type 1 infection and disease progres
herapy: Implications for eradication/Latent viral reservoirs in
of HIV-1 and hepatitis B (HBV) in mixed infection/Interaction
man immunodeficiency type 1 population bottleneck during i
mian immunodeficiency (SIV)/Requirement of each glycan in
man immunodeficiency in vivo: The envelope gene/Evolutio

32297
32306
32379
42154
42166
42276
42422
60433
60518
60667
12294
12297
12338
22338
32281
32319
32350
60702
60812
265*/11154
12134
12193
12334
13351
32114
41222
42275
42395
60487
60703
24101
41117
33170
60370
60780
11197
41111
11178
11226
22297
598*/31130
13369
11121
11143
11147
273*/11150
11160
11185
11212
11219

mian immunodeficiency
ne immunodeficiency
ecombinant canarypox
ort/Prognostic value of
man immunodeficiency
man inmunodeficiency
dinavir who experience
s in HIV and hepatitis C
V and hepatitis B and C
ationship of hepatitis B
mophiliacs/Hepatitis C
nfants/Virus detection,
ency virus/Site specific
body to Herpes simplex
tin level correlates with
man immunodeficiency
I: Circulating subtypes,
ed reduction in plasma
response to hepatitis C
man immunodeficiency
a recombinant vaccinia
d using a Semliki forest
man immunodeficiency
sion of herpes simplex
dly evolving hepatitis C
ection/Detection of GB
enotypes of hepatitis G
thy/Quantitation of JC
nce of human papilloma
mes/Human papilloma
) and human papiloma
lopathy/Analysis of JC
e undetectable plasma
Durable suppression of
f HIV and of hepatitis A
man inmunodeficiency
man immunodeficiency
patitis C and hepatitis G
man immunodeficiency
man immunodeficiency
man immunodeficiency
hages with autologous
ction by human herpes
n levels using vaccinia
-infection on hepatitis C
of a precore hepatitis B
ed women/Cytomegalo
PML)/Detection of JC
PORN)/Varicella zoster
y, relation to hepatitis C
an immunodeficiency
on and quantification of
ction by herpes simplex
ith the AIDS causing
y/Quantitation of HIV-1
man immunodeficiency
solation and cloning of
man immunodeficiency
man immunodeficiency
man immunodeficiency
man immunodeficiency
orrelate with infectious
man immunodeficiency
HULs)/Fighting a "new"
nts associated with HIV
apan/HIV and hepatitis
ge city/Varicella zoster
e (ATV) using a sendai
man immunodeficiency
man immunodeficiency
ostimulation increases
man immunodeficiency
atients?/Epstein-Barr
ents/Human papilloma
by respiratory syncytial

man immunodeficiency
man immunodeficiency
n-progressors with high
e of the detection of JC
e epidemiology of slow

- Keyword Abstr
acute infection and CCR5, CCR1, IF
) infected laboratory cats/A prospecti
/CTL induction in macaques using int
load levels in patients receiving HAA
type 1 with zidovudine (ZDV) treatme
type 1 - Infected individuals from Boli
load declines to <500 vRNA copies/
(HCV) co-infected patients/Efficacy
among injecting drug users admitted
and HIV seropositivity in a group of m
(HCV) genotypes and progression of
load, and disease progression in peri
load in the reproductive tract tissues
type 2 as a marker of sexual risk beh
load in pediatric HIV infection/Plasm
type 1 Nef protein quasi-species fro
isolation, plasma viral load, and clinic
load leads to decrease in lymphocyte
antigens/HIV-infection alters T cell i
/Production of monokines in peripher
system/Antigenicity of HIV-1-like Ga
vector/Antigenicity of HIV-1 envelop
(HIV)/Tuberculous lymphadenitis in
infections among women enrolled in t
infection in HIV co-infected patients t
-C/hepatitis G virus (GBV-C/HGV) a
and hepatitis C virus among HIV infe
in CSFAND urine prognostic value of
(HPV) infection in HIV-positive and H
(HPV) in HIV+ women: An assessme
(HPV) in HIV-positive and HIV-negati
molecular characteristics influencing
/HIV replication persists in patients re
replication with saquinavir in combin
infection during an intravenous opiat
/Risk factors for blood donors with se
/A "Bloodless cesarean section" and
in women with triple infection/Matern
(HIV) post-exposure prophylaxis/Pr
in Chilean women/Transmission wa
(HIV) infection in sexually active Gha
isolates/Sera from early seroconvert
type 8 in the US and Africa/Compara
recombinants expressing human cyt
(HCV)-infection in hemophiliacs and
mutant infection with lamivudine-con
and herpes simplex virus are not ass
(JCV) DNA in blood cell sub-populati
associated with rapidly progressive o
and HIV-viral load/Erythema of the p
(HIV): Comparison between an out-p
load/Heat-denatured p24 antigen te
in mice/Nonoxynol-9 enhances rect
/Journalists role in creating awarene
load by a TaqManTM-based product e
in Ukraine/Genotypic analysis of hu
/Establishment of HeLa/CD4-LTR-/type 1 (HIV-1) subtype on HIV antibo
type 1 activities of proteins from 17 s
type 1 activity/Structure/function rela
(HIV) activity, of NARL-1, an polycas
in patients on passive immunotherap
/A new approach for developing a sel: Highly useless laws (HULs)/Fightin
infection/Admission criteria, treatme
infection among drug users in Japan
infection in adults in the large city/Va
envelope derived adjuvant/Studies
type 1 replication in vitro/Human lact
(HIV) to first opportunistic infection/P
replication in CD4+ cells naturally or
type 1 env subtypes B and A in Frenc
(EBV) PCR of CSF: Is it useful in the

(HPV) lesions in HIV+ and AIDS pati
infection (RSV): A case report/Delay
(HIV)/Co-infection of central nervou
type 1 subtype C isolates of Ethiopia
load/Virological and immunological
DNA by nested polymerase chain re
es: New findings on human immunod

act
11222
11236
11243
12129
12155
12178
12279
12326
13224
13301
13306
13369
13385
14117
21115
21142
21154
21163
21182
21188
21204
21207
22147
22191
17*/22243
22250
22264
22266
22303
22315
22316
22322
22388
22395
23211
23256
23274
23293
23330
23478
23593
31105
31189
31199
32107
32118
32135
32210
32246
32268
32380
32442
33143
33513
41137
41161
41163
41173
41203
41206
41207
41236
41251
44114
44197
60087
60267
60312
60342
60360
60407
60425
60496

60560
60597
60605
60692
60702
60734
60738